Availability of dose optionsAvailability of drug choice combinationsAccess to fixed dose combinationsCost (inconsistent coverage)Inconsistent guideline recommendations for blood pressure goals and usePrescriber reluctance
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.Circulation. 2025;151:e41–660. [DOI] [PubMed]
Bourque G, Ilin JV, Ruzicka M, Hundemer GL, Shorr R, Hiremath S. Nonadherence Is Common in Patients With Apparent Resistant Hypertension: A Systematic Review and Meta-analysis.Am J Hypertens. 2023;36:394–403. [DOI] [PubMed]
Olsen E, Halvorsen LV, Rognstad S, Aune A, Brobak KM, Bergland OU, et al. Characteristics of adherent and non-adherent patients with hypertension in a Norwegian cross-sectional study.Explor Med. 2025;6:1001279. [DOI]
Mancia G, Cappuccio FP, Burnier M, Coca A, Persu A, Borghi C, et al. Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension.J Intern Med. 2023;294:251–68. [DOI] [PubMed]
Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S. Better drug adherence improves blood pressure control and lowers cardiovascular disease outcomes – from single pill combinations to monitoring of a nationwide health insurance database.Blood Press. 2021;30:143–4. [DOI] [PubMed]
Choudhry NK, Kronish IM, Vongpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, et al.; American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association.Hypertension. 2022;79:e1–14. [DOI] [PubMed] [PMC]
Simonyi G, Burnier M, Narkiewicz K, Rokszin G, Abonyi-Tóth Z, Kovács G, et al. Effect of single-pill versus free equivalent combinations on persistence and major adverse cardiovascular events in hypertension: a real-world analysis.J Hypertens. 2025;43:405–12. [DOI] [PubMed] [PMC]
Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, et al.; GMRx2 Investigators. Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.Lancet. 2024;404:1536–46. [DOI] [PubMed]
Ojji DB, Salam A, Sani MU, Ogah OS, Schutte AE, Huffman MD, et al. Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria: A Randomized Clinical Trial.JAMA. 2024;332:1070–9. [DOI] [PubMed] [PMC]
Nash DT. Rationale for combination therapy in hypertension management: focus on angiotensin receptor blockers and thiazide diuretics.South Med J. 2007;100:386–92. [DOI] [PubMed]
Weir MR. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.J Hum Hypertens. 2007;21:770–9. [DOI] [PubMed]
Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, et al. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.Clin Ther. 2007;29:563–80. [DOI] [PubMed]
Pimenta E, Oparil S. Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination.Vasc Health Risk Manag. 2008;4:653–64. [DOI] [PubMed] [PMC]
Molina de Salazar DI, Coca A, Alcocer L, Piskorz D. The Rationale for Using Fixed-Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review.Am J Cardiovasc Drugs. 2024;24:197–209. [DOI] [PubMed] [PMC]
Wang B, Choudhry NK, Gagne JJ, Landon J, Kesselheim AS. Availability and utilization of cardiovascular fixed-dose combination drugs in the United States.Am Heart J. 2015;169:379–86.e1. [DOI] [PubMed]
O’Hagan E, McIntyre D, Nguyen T, Tan KM, Hanlon P, Siddiqui M, et al. A Cross-Sectional Survey of Fixed-Dose Combination Antihypertensive Medicine Prescribing in Twenty-Four Countries, Including Qualitative Insights.Glob Heart. 2024;19:73. [DOI] [PubMed] [PMC]
Bryan AS, Moran AE, Mobley CM, Derington CG, Rodgers A, Zhang Y, et al. Cost-effectiveness analysis of initial treatment with single-pill combination antihypertensive medications.J Hum Hypertens. 2023;37:985–92. [DOI] [PubMed] [PMC]
Morabito G, Gregorio C, Ieva F, Barbati G, Mancia G, Corrao G, et al. Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study.BMC Public Health. 2024;24:1808. [DOI] [PubMed] [PMC]
King JB, Derington CG, Herrick JS, Jacobs JA, Zheutlin AR, Conroy MB, et al. Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial.Hypertension. 2023;80:1749–58. [DOI] [PubMed] [PMC]
Shimbo D, Artinian NT, Basile JN, Krakoff LR, Margolis KL, Rakotz MK, et al.; American Heart Association and the American Medical Association. Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association.Circulation. 2020;142:e42–63. [DOI] [PubMed]
Zhang D, Huang QF, Li Y, Wang JG. A randomized controlled trial on home blood pressure monitoring and quality of care in stage 2 and 3 hypertension.Hypertens Res. 2021;44:533–40. [DOI] [PubMed]
Satoh M, Metoki H, Murakami T, Tatsumi Y, Asayama K, Kikuya M, et al. Home blood pressure control and prescribing patterns of anti-hypertensive medications in a home blood pressure-based hypertension-specialized clinic in Japan: a sub-analysis of the Ohasama study.Hypertens Res. 2025;48:26–36. [DOI] [PubMed] [PMC]
Mukkamala R, Shroff SG, Landry C, Kyriakoulis KG, Avolio AP, Stergiou GS. The Microsoft Research Aurora Project: Important Findings on Cuffless Blood Pressure Measurement.Hypertension. 2023;80:534–40. [DOI] [PubMed] [PMC]
Schutte AE. Wearable cuffless blood pressure tracking: when will they be good enough?J Hum Hypertens. 2024;38:669–72. [DOI] [PubMed] [PMC]
Schutte AE. The promise and pitfalls of novel cuffless blood pressure devices.Eur Heart J. 2022;43:4222–3. [DOI] [PubMed]
Sayer G, Piper G, Vorovich E, Raikhelkar J, Kim GH, Rodgers D, et al. Continuous Monitoring of Blood Pressure Using a Wrist-Worn Cuffless Device.Am J Hypertens. 2022;35:407–13. [DOI] [PubMed]
Quisel T, Foschini L, Zbikowski SM, Juusola JL. The Association Between Medication Adherence for Chronic Conditions and Digital Health Activity Tracking: Retrospective Analysis.J Med Internet Res. 2019;21:e11486. [DOI] [PubMed] [PMC]
Nolan RP, Feldman R, Dawes M, Kaczorowski J, Lynn H, Barr SI, et al. Randomized Controlled Trial of E-Counseling for Hypertension: REACH.Circ Cardiovasc Qual Outcomes. 2018;11:e004420. [DOI] [PubMed]
McManus RJ, Little P, Stuart B, Morton K, Raftery J, Kelly J, et al.; HOME BP investigators. Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial.BMJ. 2021;372:m4858. [DOI] [PubMed] [PMC]
Ogedegbe G, Teresi JA, Williams SK, Ogunlade A, Izeogu C, Eimicke JP, et al. Home Blood Pressure Telemonitoring and Nurse Case Management in Black and Hispanic Patients With Stroke: A Randomized Clinical Trial.JAMA. 2024;332:41–50. [DOI] [PubMed] [PMC]
Lora Mantilla AJ, Parra Gomez LA, Camacho-López PA, Otero-Wandurraga J, Novella B, González-Medina A, et al. Community-based model for management and follow-up by non-physician healthcare workers to improve awareness, treatment, and control of hypertension: The COTRACO study protocol.Heliyon. 2025;11:e41726. [DOI] [PubMed] [PMC]
Sim I. Mobile Devices and Health.N Engl J Med. 2019;381:956–68. [DOI] [PubMed]
Kaihara T, Intan-Goey V, Scherrenberg M, Falter M, Kario K, Akashi Y, et al. Automatic transmission of home blood pressure data can be effective in managing hypertension: a systematic review and meta-analysis.Eur Heart J Digit Health. 2022;3:638–53. [DOI] [PubMed] [PMC]
Bradley CK, Shimbo D, Colburn DA, Pugliese DN, Padwal R, Sia SK, et al. Cuffless Blood Pressure Devices.Am J Hypertens. 2022;35:380–7. [DOI] [PubMed] [PMC]
Woods SB, Udezi V, Roberson PNE, Arnold EM, Nesbitt S, Hiefner A. “A cuff is not enough”: A community-based participatory research approach to soliciting perspectives of African Americans with hypertension and their family members on self-management intervention features.Fam Process. 2024;63:731–48. [DOI] [PubMed] [PMC]
Xie Z, Liu K, Or C, Chen J, Yan M, Wang H. An examination of the socio-demographic correlates of patient adherence to self-management behaviors and the mediating roles of health attitudes and self-efficacy among patients with coexisting type 2 diabetes and hypertension.BMC Public Health. 2020;20:1227. [DOI] [PubMed] [PMC]
Huang YM, Shiyanbola OO, Chan HY, Smith PD. Patient factors associated with diabetes medication adherence at different health literacy levels: a cross-sectional study at a family medicine clinic.Postgrad Med. 2020;132:328–36. [DOI] [PubMed]
Heredia NI, Garza ER, Velasco-Huerta F, Swoboda TL, Fwelo P, Mathews PD, et al. Implementation of healthy heart ambassador to improve blood pressure control at community health centers in Texas.BMC Health Serv Res. 2024;24:1105. [DOI] [PubMed] [PMC]
Grant B, Myers K, Patterson H, Suthar I, Garst K, James M, et al. Virtual Expansion of the YMCA’s Blood Pressure Self-Monitoring (BPSM) Program: Using Telehealth to Adapt an Evidence-Based Program to Reach Rural Communities in South Carolina.J Public Health Manag Pract. 2024;30:S89–95. [DOI] [PubMed]
Ravenell J, Green T, Arabadjian M, Schoenthaler A, Ogedegbe O. Barbershop-Facilitated Community-to-Clinic Linkage Implementation Program: Rationale and Protocol for a Novel Program to Prevent Hypertension Among Black Men.Am J Hypertens. 2023;36:240–7. [DOI] [PubMed] [PMC]
Victor RG, Ravenell JE, Freeman A, Leonard D, Bhat DG, Shafiq M, et al. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial.Arch Intern Med. 2011;171:342–50. [DOI] [PubMed] [PMC]
Inagaki Y, Matsushita K, Appel LJ, Perry HB, Neupane D. Task-sharing with community health workers to treat hypertension: a scoping review.J Hypertens. 2024;42:2041–54. [DOI] [PubMed] [PMC]
Katz ME, Mszar R, Grimshaw AA, Gunderson CG, Onuma OK, Lu Y, et al. Digital Health Interventions for Hypertension Management in US Populations Experiencing Health Disparities: A Systematic Review and Meta-Analysis.JAMA Netw Open. 2024;7:e2356070. [DOI] [PubMed] [PMC]
Brownstein JN, Chowdhury FM, Norris SL, Horsley T, Jack L Jr, Zhang X, et al. Effectiveness of community health workers in the care of people with hypertension.Am J Prev Med. 2007;32:435–47. [DOI] [PubMed]
Schutte AE, Srinivasapura Venkateshmurthy N, Mohan S, Prabhakaran D. Hypertension in Low- and Middle-Income Countries.Circ Res. 2021;128:808–26. [DOI] [PubMed] [PMC]
Tsoi K, Yiu K, Lee H, Cheng HM, Wang TD, Tay JC, et al.; HOPE Asia Network. Applications of artificial intelligence for hypertension management.J Clin Hypertens (Greenwich). 2021;23:568–74. [DOI] [PubMed] [PMC]
Kario K, Tomitani N, Wang TD, Park S, Li Y, Shin J, et al. Home blood pressure-centered approach – from digital health to medical practice: HOPE Asia Network consensus statement 2023.Hypertens Res. 2023;46:2561–74. [DOI] [PubMed]
Springer MV, Malani P, Solway E, Kirch M, Singer DC, Kullgren JT, et al. Prevalence and Frequency of Self-measured Blood Pressure Monitoring in US Adults Aged 50-80 Years.JAMA Netw Open. 2022;5:e2231772. [DOI] [PubMed] [PMC]
Sarkar A, Nwokocha C, Nash SG, Grigoryan L. Empowering Low-Income Patients with Home Blood Pressure Monitors to Improve Hypertension Control.J Am Board Fam Med. 2024;37:187–95. [DOI] [PubMed]
Arrieta A, Woods JR, Qiao N, Jay SJ. Cost-benefit analysis of home blood pressure monitoring in hypertension diagnosis and treatment: an insurer perspective.Hypertension. 2014;64:891–6. [DOI] [PubMed]
Arrieta A, Woods J, Wozniak G, Tsipas S, Rakotz M, Jay S. Return on investment of self-measured blood pressure is associated with its use in preventing false diagnoses, not monitoring hypertension.PLoS One. 2021;16:e0252701. [DOI] [PubMed] [PMC]
Holko M, Litwin TR, Munoz F, Theisz KI, Salgin L, Jenks NP, et al. Wearable fitness tracker use in federally qualified health center patients: strategies to improve the health of all of us using digital health devices.NPJ Digit Med. 2022;5:53. [DOI] [PubMed] [PMC]
Yap AF, Thirumoorthy T, Kwan YH. Systematic review of the barriers affecting medication adherence in older adults.Geriatr Gerontol Int. 2016;16:1093–101. [DOI] [PubMed]
